BMS 275183
BMS 275183 is a potent, orally active analogue of Paclitaxel. It stabilizes microtubules and exhibits antitumor activity in in vivo tumor models. BMS 275183 is also effective in vitro against Paclitaxel-resistant tumors, including those with tubulin mutations or overexpression of P-glycoprotein. It is applicable in cancer research, such as in non-small cell lung cancer (NSCLC) and prostate cancer studies.
Product Specifications
CAS Number
355113-98-3
Smiles
O (C (OC) =O) [C@]12[C@]3 ([C@H] (OC (=O) C4=CC=CC=C4) [C@@]5 (O) C (C) (C) C ([C@@H] (OC (C) =O) C (=O) [C@]3 (C) [C@@H] (O) C[C@]1 (OC2) [H]) =C (C) [C@@H] (OC ([C@@H] ([C@@H] (NC (OC (C) (C) C) =O) C (C) (C) C) O) =O) C5) [H]
Molecular Formula
C43H59NO16
Molecular Weight
845.94
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP53339_P050 100 µL
CHMP4B antibody - middle region (ARP53339_P050)
Sign In for Pricing
View Details 
MBS6364189-01 0.1 mL
YAP, ID (S127) (YAP1, YAP65, Yorkie homolog, 65kD Yes-associated protein) (MaxLight 550)
Sign In for Pricing
View Details